Norfleet, Armond v. Webster, Thomas
Opinion
In the
United States Court of Appeals For the Seventh Circuit
No. 05-1237 ARMOND NORFLEET, Plaintiff-Appellee,
v.
THOMAS WEBSTER and ALEJANDRO HADDED, Defendants-Appellants.
Appeal from the United States District Court for the Southern District of Indiana, Indianapolis Division.
No. 03 C 458—David F. Hamilton, Judge.
ARGUED NOVEMBER 28, 2005—DECIDED MARCH 3, 2006
Before KANNE, ROVNER, and WOOD, Circuit Judges. KANNE, Circuit Judge. Armond Norfleet suffers from arthritis. While incarcerated in a federal prison at Milan, Michigan (“Milan”), Norfleet was given certain medical treatments for his arthritis, including Naprosyn and soft- soled shoes for his aching feet. On May 22, 2002, he was transferred to the federal prison at Terre Haute, Indiana (“Terre Haute”), where the medical authorities were not as sympathetic to his joint problems. A doctor at Terre Haute concluded the soft-soled shoes and other treatments were unnecessary, and pursuant to prison policy the drugs Norfleet had been taking for his pain were curtailed. Norfleet sued, naming five prison officials, claiming that they had been deliberately indifferent to his serious medical needs in violation of the Eighth Amend-
2 No. 05-1237
ment. The district court granted summary judgment to three of the defendants, but denied it as to Dr. Thomas Webster, Clinical Director at Terre Haute in charge of the medical care and treatment of all inmates, and physician assistant Alejandro Hadded, whose duties included scheduling appointments for inmates to receive their prescribed drugs. Before us is the government’s appeal of that denial. Seeing things differently than the district court, and agreeing with the government, we reverse.
I. HISTORY
Norfleet’s history of treatment for arthritis is relevant to the disposition of this case, so we will recite it in necessary detail. In 1994 Norfleet was given a medical prescription for soft-soled shoes, which provide more padding and support than the standard prison-issued shoes. In that year Norfleet also had his work classification status changed so that he would not be required to wear steel-toed shoes, which because of their weight would aggravate any pain and long-term effects associated with serious arthritis.
Medical records from 1998 indicate that Norfleet not only had arthritic pain, but was also positive for rheumatoid factor, an antibody in the blood that is an indication of rheumatoid arthritis, which can be a severe and debilitating form of arthritis. Norfleet was again examined for arthritis while housed at Milan in 1999. X-rays were taken of his hands, feet, and ankles, all of which were suspicious for rheumatoid arthritis.1 Further x-rays still raised “suspicions ,” but this time the diagnosis was merely minimal rheumatoid arthritis.
1 The government has informed us, without opposition from Norfleet, that “ ‘suspicious for’ is a medical ‘hedge’ term that indicates a degree of uncertainty about the diagnosis.”
No. 05-1237 3
By 2001 Norfleet appeared to be getting better. New x-rays showed improvement, and a rheumatoid factor lab test taken on July 23, 2001, was negative for rheumatoid arthritis. On October 13, 2001, a physician at Milan determined that Norfleet’s “disease [was] not serious enough to warrant soft shoes.”
Less positive evaluations followed less than four months later, on February 6, 2002, when Norfleet was examined by Dr. Eugene Y. Su, a doctor outside of the prison. Dr. Su determined that the results of an examination were consistent with rheumatoid arthritis. The treatment plan developed by Dr. Su included a suggested increase of Naprosyn (a nonsteroidal, anti-inflammatory drug), and the doctor’s opinion that Norfleet “would benefit from better shoes with more padding/support.” On March 2, 2002, the authorities at Milan allowed Norfleet to have soft-soled shoes for a period of six months.
About three months later, on May 22, 2002, Norfleet was transferred to Terre Haute. Shortly after his arrival, prison authorities confiscated Norfleet’s soft-soled shoes because he did not have authorization from Terre Haute to wear them. At about the same time, though the record is not entirely clear on the sequence, Dr. Webster reviewed Norfleet’s medical files. On July 18, 2002, Dr. Webster noted in a medical record that Norfleet had a “past [history] of rheumatoid arthritis,” “minor deformities in toes,” and “minor RA [rheumatoid arthritis] changes in toes.” Physician assistants at Terre Haute made similar entries in Norfleet’s medical records, some of which can be read as a more definitive and serious diagnosis of Norfleet’s condition, e.g., that Norfleet “suffers from rheumatoid arthritis.” (emphasis added). Dr. Webster’s ultimate determination, however, was that Norfleet had minimal arthritis, not rheumatoid arthritis. Accordingly, Dr. Webster concluded that Norfleet did not require soft-soled shoes, which resulted in Norfleet being forced to wear the less 4 No. 05-1237
comfortable prison-issued shoes. Dr. Webster also curtailed or discontinued other medications.2 During this time, Norfleet continued to receive Naprosyn for his pain. In fact, on December 30, 2003, a pharmacist stated in medical records that Norfleet was “authorized by Dr. Webster to receive Naprosyn.” On February 12, 2003, a number of months after the confiscation of his soft-soled shoes, Norfleet reported to Health Services at Terre Haute to obtain a refill of his prescribed Naprosyn. Hadded, a low- level employee who was manning the desk at Health Services, refused to just fill Norfleet’s prescription. Instead, following the prison’s written medical policy, Hadded scheduled an appointment for Norfleet thirteen days out, which resulted in Norfleet going twelve days without his pain medication. It is undisputed that as of January 17, 2003, Terre Haute had implemented a new policy to deal with the abuse and possible side effects of unbroken use of certain prescription drugs, including the Naprosyn taken by Norfleet. The policy required that an inmate requesting a refill of Naprosyn had to wait at least ten days for a refill, but not more than fourteen.
2 Norfleet emphasizes a number of facts not relied upon by the district court. He makes note of the fact that in addition to having his soft-soled shoes revoked, his Plaquenil prescription and associated eye exams, and treatment at the Chronic Care Clinic were discontinued. It is not clear how or why Norfleet began treatment at the Chronic Care Clinic, but the record is clear that Dr. Su’s treatment plan included a prescription for Plaquenil, a drug used to treat arthritis. The eye exams presumably were necessary to monitor the side effects of Plaquenil, which include vision problems. We have considered these facts, as well as all other properly supported facts asserted by Norfleet in his brief, but they do not change our determination that the record cannot support a claim of deliberate indifference on the part of either defendant.
No. 05-1237 5
II. ANALYSIS
As the district court’s ruling was on a motion for summary judgment, our review is de novo, and we construe all disputed facts in the light most favorable to Norfleet. See Garvin v. Armstrong, 236 F.3d 896, 898 (7th Cir. 2001) (citations omitted). On an appeal from the government contesting the denial of qualified immunity, we will not second-guess the district court’s determination regarding a dispute of fact, though we will review the district court’s determination that a set of facts can overcome a qualified immunity defense. Board v. Farnham, 394 F.3d 469, 476 (7th Cir. 2005) (citation omitted). The threshold question concerning a qualified immunity defense is whether there is any merit to the underlying constitutional claim. Riccardo v. Rausch, 375 F.3d 521, 526 (7th Cir. 2004) (citing Saucier v. Katz, 533 U.S. 194, 201 (2001)).
Free access — add to your briefcase to read the full text and ask questions with AI
Norfleet, Armond v. Webster, Thomas (Norfleet, Armond v. Webster, Thomas) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.